202 related articles for article (PubMed ID: 20972932)
1. [Multiparametric MRI of the prostate: method for early detection of prostate cancer?].
Schlemmer HP
Rofo; 2010 Dec; 182(12):1067-75. PubMed ID: 20972932
[TBL] [Abstract][Full Text] [Related]
2. [Multiparametric magnetic resonance imaging of the prostate - technique and clinical applications].
Franiel T
Rofo; 2011 Jul; 183(7):607-17. PubMed ID: 21487980
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer.
Yoshizako T; Wada A; Hayashi T; Uchida K; Sumura M; Uchida N; Kitagaki H; Igawa M
Acta Radiol; 2008 Dec; 49(10):1207-13. PubMed ID: 19031184
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced magnetic resonance imaging in prostate cancer.
Kayhan A; Fan X; Oto A
Top Magn Reson Imaging; 2009 Apr; 20(2):105-12. PubMed ID: 20010065
[TBL] [Abstract][Full Text] [Related]
5. [Multiparametric MRI for prostate cancer screening].
Hoeks CM; Fütterer JJ; Somford DM; van Oort IM; Huisman H; Barentsz JO
Ned Tijdschr Geneeskd; 2009; 153():B487. PubMed ID: 20003566
[TBL] [Abstract][Full Text] [Related]
6. [Dynamic contrast-enhanced MRI of the prostate: comparison of two different post-processing algorithms].
Beyersdorff D; Lüdemann L; Dietz E; Galler D; Marchot P; Franiel T
Rofo; 2011 May; 183(5):456-61. PubMed ID: 21442558
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer detection in men with prostate specific antigen 4 to 10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy.
Pelzer A; Bektic J; Berger AP; Pallwein L; Halpern EJ; Horninger W; Bartsch G; Frauscher F
J Urol; 2005 Jun; 173(6):1926-9. PubMed ID: 15879783
[TBL] [Abstract][Full Text] [Related]
8. Dynamic contrast-enhanced MR imaging in the evaluation of patients with prostate cancer.
McMahon CJ; Bloch BN; Lenkinski RE; Rofsky NM
Magn Reson Imaging Clin N Am; 2009 May; 17(2):363-83. PubMed ID: 19406364
[TBL] [Abstract][Full Text] [Related]
9. MR-perfusion (MRP) and diffusion-weighted imaging (DWI) in prostate cancer: quantitative and model-based gadobenate dimeglumine MRP parameters in detection of prostate cancer.
Scherr MK; Seitz M; Müller-Lisse UG; Ingrisch M; Reiser MF; Müller-Lisse UL
Eur J Radiol; 2010 Dec; 76(3):359-66. PubMed ID: 20471189
[TBL] [Abstract][Full Text] [Related]
10. [MRI of prostate cancer using three different coil systems: image quality, tumor detection, and staging].
Beyersdorff D; Darsow U; Stephan C; Schnorr D; Loening S; Taupitz M
Rofo; 2003 Jun; 175(6):799-805. PubMed ID: 12811693
[TBL] [Abstract][Full Text] [Related]
11. Prostate cancer screening: the clinical value of diffusion-weighted imaging and dynamic MR imaging in combination with T2-weighted imaging.
Tanimoto A; Nakashima J; Kohno H; Shinmoto H; Kuribayashi S
J Magn Reson Imaging; 2007 Jan; 25(1):146-52. PubMed ID: 17139633
[TBL] [Abstract][Full Text] [Related]
12. Dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) is a useful modality for the precise detection and staging of early prostate cancer.
Hara N; Okuizumi M; Koike H; Kawaguchi M; Bilim V
Prostate; 2005 Feb; 62(2):140-7. PubMed ID: 15389803
[TBL] [Abstract][Full Text] [Related]
13. Multiparametric magnetic resonance imaging of the prostate: current status in prostate cancer detection, localization, and staging.
Macura KJ
Semin Roentgenol; 2008 Oct; 43(4):303-13. PubMed ID: 18774034
[No Abstract] [Full Text] [Related]
14. [Staging of prostate cancer: value of the combined information of endorectal MRI, biopsy Gleason score, and preoperative PSA level].
Wetter A; Ajdukovic AN; Fliessbach K; Lehnert T; Engl T; Jacobi V; Vogl TJ
Rofo; 2006 Apr; 178(4):385-90. PubMed ID: 16607587
[TBL] [Abstract][Full Text] [Related]
15. Automated detection of prostatic adenocarcinoma from high-resolution ex vivo MRI.
Madabhushi A; Feldman MD; Metaxas DN; Tomaszeweski J; Chute D
IEEE Trans Med Imaging; 2005 Dec; 24(12):1611-25. PubMed ID: 16350920
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric magnetic resonance imaging in the detection of prostate cancer.
Durmus T; Baur A; Hamm B
Aktuelle Urol; 2014 Mar; 45(2):119-26. PubMed ID: 24700068
[TBL] [Abstract][Full Text] [Related]
17. Analysis of prostate DCE-MRI: comparison of fast exchange limit and fast exchange regimen pharmacokinetic models in the discrimination of malignant from normal tissue.
Lowry M; Zelhof B; Liney GP; Gibbs P; Pickles MD; Turnbull LW
Invest Radiol; 2009 Sep; 44(9):577-84. PubMed ID: 19668002
[TBL] [Abstract][Full Text] [Related]
18. Evaluating localized prostate cancer and identifying candidates for focal therapy.
Sartor AO; Hricak H; Wheeler TM; Coleman J; Penson DF; Carroll PR; Rubin MA; Scardino PT
Urology; 2008 Dec; 72(6 Suppl):S12-24. PubMed ID: 19095124
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of serum markers for prostate cancer.
Stenman UH; Abrahamsson PA; Aus G; Lilja H; Bangma C; Hamdy FC; Boccon-Gibod L; Ekman P
Scand J Urol Nephrol Suppl; 2005 May; (216):64-81. PubMed ID: 16019759
[TBL] [Abstract][Full Text] [Related]
20. [MR-guided interventions of the prostate gland: a literature review].
Zangos S; Eichler K; Thalhammer A; Mack MG; Marquardt F; Vogl TJ
Rofo; 2010 Nov; 182(11):947-53. PubMed ID: 20725875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
